Commercial & Market Access Consultancy
UK & EU Genomics Markets
Entering the UK and European genomics markets requires more than distributors, local hires, or generic sales contracts. It requires trusted relationships, technical credibility, and commercial execution grounded in how these markets actually buy.
Amped PCR provides specialist commercial and market access consultancy for US and international genomics companies expanding into the UK and EU. We help companies establish presence, generate traction, and convert technical differentiation into sustained revenue.
Why Amped PCR
Amped PCR’s leadership brings over a decade of senior commercial experience across PCR, qPCR, genomics, and molecular diagnostics markets in the UK, Europe, and the US.
We have delivered commercial execution for growth-stage and portfolio companies including:
• NuGEN / Tecan Genomics
• Nostos Genomics
In these roles we exceeded regional sales targets, ranked within the top three performers across global portfolios, and built durable pipelines across academic, clinical, and industrial markets.
This experience now underpins our consultancy offering.
What We Do
We provide commercial execution, not theory.
Our services include:
• UK and EU go-to-market strategy for genomics and molecular biology products
• Distributor selection, onboarding, and performance management
• Direct sales into core labs, service labs, and enterprise accounts
• Pricing, positioning, and competitive strategy
• Technical to commercial translation for complex workflows and platforms
• Early customer access, reference building, and market intelligence
We operate as a fractional commercial team aligned to outcomes, not headcount.
Physical Presence Where It Matters
Amped PCR can act as your physical commercial presence at key UK and European industry events, conferences, and customer meetings.
This includes:
• Representing your company at major genomics and life sciences events
• Meeting customers and partners on your behalf
• Supporting product launches, pilots, and early adopter engagement
• Providing credible, technically fluent representation without the cost of permanent regional staff.
For US companies, this enables immediate visibility and engagement in the market without building local infrastructure prematurely.
Designed for US Companies Entering Europe
UK and EU genomics markets are fragmented, relationship-driven, and slower to adopt than the US. Procurement, validation, and decision-making differ significantly.
Amped PCR operates inside this reality.
We understand how labs buy, how distributors behave, and where sales processes succeed or fail. We help companies avoid costly missteps that delay traction by twelve to twenty-four months.
Remote-First, Results-Driven
Amped PCR operates a proven remote-first commercial model that has consistently outperformed traditional field-based sales structures.
This approach enables broader geographic coverage, faster response times, stronger technical continuity, and materially lower overhead. It has delivered repeatable results across multiple portfolios.
Why This Model Beats Traditional Contracts
Compared to hiring regional staff or signing long-term distributor agreements, Amped PCR consultancy offers:
• Lower risk with no permanent headcount or long lock-ins
• Faster traction through immediate access to established networks
• Deeper market intelligence from direct customer engagement
• Aligned incentives focused on revenue, not activity
• Credibility through partnership with an active genomics company
This is a capital-efficient, execution-led alternative to conventional expansion models.
A Strategic Commercial Partner
Amped PCR does not operate as a generic sales agency.
We act as a strategic commercial extension of your team, embedded, accountable, and focused on building real market presence and revenue in the UK and EU.